Study To Evaluate Long Term Treatment Effect Of Diapep277® In Patients Who Have Completed Study 901 And Study 910** (Extension To 901)

The recruitment status of this study is unknown because the information has not been verified recently.

Verified January 2011 by Hadassah Medical Organization.
Recruitment status was Not yet recruiting

Sponsor:

Collaborator:

DIABETES UNIT

Information provided by:

Hadassah Medical Organization

ClinicalTrials.gov Identifier:

NCT01281072

First received: January 20, 2011

Last updated: NA

Last verified: January 2011

History: No changes posted

Tracking Information
First Received Date ^ICMJE	January 20, 2011
Last Updated Date	January 20, 2011
Start Date ^ICMJE	Not Provided
Primary Completion Date	Not Provided
Current Primary Outcome Measures ^ICMJE (submitted: January 20, 2011)	c peptide reserve
Original Primary Outcome Measures ^ICMJE	Same as current
Change History	No Changes Posted
Current Secondary Outcome Measures ^ICMJE	Not Provided
Original Secondary Outcome Measures ^ICMJE	Not Provided
Current Other Outcome Measures ^ICMJE	Not Provided
Original Other Outcome Measures ^ICMJE	Not Provided

Descriptive Information
Brief Title ^ICMJE	Study To Evaluate Long Term Treatment Effect Of Diapep277® In Patients Who Have Completed Study 901 And Study 910** (Extension To 901)
Official Title ^ICMJE	Not Provided
Brief Summary	Open label study to evaluate long term treatment effect of diapep277.
Detailed Description	Not Provided
Study Type ^ICMJE	Interventional
Study Phase	Phase 3
Study Design ^ICMJE	Intervention Model: Single Group Assignment
Condition ^ICMJE	Giving a Vaccination in Three Months
Intervention ^ICMJE	Other: vaccine
Study Arm (s)	Not Provided
Publications *	Not Provided
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information
Recruitment Status ^ICMJE	Not yet recruiting
Enrollment ^ICMJE	Not Provided
Completion Date	Not Provided
Primary Completion Date	Not Provided
Eligibility Criteria ^ICMJE	Inclusion Criteria: 1. patient that completed 901 and 910 study. Exclusion Criteria: 1. cpeptide<0.2
Gender	Both
Ages	20 Years to 50 Years
Accepts Healthy Volunteers	Not Provided
Contacts ^ICMJE	Not Provided
Location Countries ^ICMJE	Not Provided

Administrative Information
NCT Number ^ICMJE	NCT01281072
Other Study ID Numbers ^ICMJE	911-DIAPEP277
Has Data Monitoring Committee	No
Responsible Party	PROP ITAMAR RAZ, HADASSAH MEDICAL CENTER
Study Sponsor ^ICMJE	Hadassah Medical Organization
Collaborators ^ICMJE	DIABETES UNIT
Investigators ^ICMJE	Not Provided
Information Provided By	Hadassah Medical Organization
Verification Date	January 2011
^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top